Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination
Angela M. Minassian, Sarah E. Silk, Jordan R. Barrett, et al.
Med (2021) Vol. 2, Iss. 6, pp. 701-719.e19
Open Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Malaria vaccines: a new era of prevention and control
Patrick E. Duffy, J. Patrick Gorres, Sara A. Healy, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 12, pp. 756-772
Closed Access | Times Cited: 19
Blood-stage malaria vaccine candidate RH5.1/Matrix-M in healthy Tanzanian adults and children; an open-label, non-randomised, first-in-human, single-centre, phase 1b trial
Sarah E. Silk, Wilmina F. Kalinga, Jo Salkeld, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1105-1117
Open Access | Times Cited: 18
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate
Robert J. Ragotte, David Pulido, Amelia M. Lias, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 40
Malaria Vaccines: Progress to Date
Danielle I. Stanisic, Michael F. Good
BioDrugs (2023) Vol. 37, Iss. 6, pp. 737-756
Open Access | Times Cited: 34
Superior antibody immunogenicity of a viral-vectored RH5 blood-stage malaria vaccine in Tanzanian infants as compared to adults
Sarah E. Silk, Wilmina F. Kalinga, Ivanny M. Mtaka, et al.
Med (2023) Vol. 4, Iss. 10, pp. 668-686.e7
Open Access | Times Cited: 27
Vaccination with Plasmodium vivax Duffy-binding protein inhibits parasite growth during controlled human malaria infection
Mimi M. Hou, Jordan R. Barrett, Yrene Themistocleous, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 704
Open Access | Times Cited: 24
Analysis of the diverse antigenic landscape of the malaria protein RH5 identifies a potent vaccine-induced human public antibody clonotype
Jordan R. Barrett, Dimitra Pipini, Nathan Wright, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4964-4980.e21
Open Access | Times Cited: 14
The Need for Novel Asexual Blood-Stage Malaria Vaccine Candidates for Plasmodium falciparum
Eizo Takashima, Hitoshi Otsuki, Masayuki Morita, et al.
Biomolecules (2024) Vol. 14, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Vaccines and monoclonal antibodies: new tools for malaria control
Kazutoyo Miura, Yevel Flores-García, Carole A. Long, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 11
The impact of Plasmodium-driven immunoregulatory networks on immunity to malaria
Michelle J. Boyle, Christian Engwerda, Prasanna Jagannathan
Nature reviews. Immunology (2024) Vol. 24, Iss. 9, pp. 637-653
Closed Access | Times Cited: 8
Current approaches to malaria vaccines
Patrick E. Duffy
Current Opinion in Microbiology (2022) Vol. 70, pp. 102227-102227
Open Access | Times Cited: 31
Updates on Malaria Epidemiology and Prevention Strategies
Marta Sanz, Pedro Berzosa, Francesca Norman
Current Infectious Disease Reports (2023) Vol. 25, Iss. 7, pp. 131-139
Open Access | Times Cited: 21
Delayed boosting improves human antigen-specific Ig and B cell responses to the RH5.1/AS01B malaria vaccine
Carolyn M. Nielsen, Jordan R. Barrett, Christine Davis, et al.
JCI Insight (2023) Vol. 8, Iss. 2
Open Access | Times Cited: 20
The PfRCR complex bridges malaria parasite and erythrocyte during invasion
Brendan Farrell, Nawsad Alam, Melissa N. Hart, et al.
Nature (2023) Vol. 625, Iss. 7995, pp. 578-584
Open Access | Times Cited: 19
A Critical Review on Human Malaria and Schistosomiasis Vaccines: Current State, Recent Advancements, and Developments
Arif Jamal Siddiqui, Jyoti Bhardwaj, Juhi Saxena, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 792-792
Open Access | Times Cited: 18
Strategic and scientific contributions of human challenge trials for vaccine development: facts versus fantasy
Yara‐Natalie Abo, Euzebiusz Jamrozik, James McCarthy, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 12, pp. e533-e546
Open Access | Times Cited: 17
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge
Irene N. Nkumama, Rodney Ogwang, Dennis Odera, et al.
Immunity (2024) Vol. 57, Iss. 6, pp. 1215-1224.e6
Open Access | Times Cited: 7
Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies
Lloyd D. W. King, David Pulido, Jordan R. Barrett, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101654-101654
Open Access | Times Cited: 6
Natural malaria infection elicits rare but potent neutralizing antibodies to the blood-stage antigen RH5
Lawrence Wang, Andrew J. R. Cooper, Brendan Farrell, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4981-4995.e14
Open Access | Times Cited: 6
Pathogenicity and virulence of malaria: Sticky problems and tricky solutions
Isobel S. Walker, Stephen J. Rogerson
Virulence (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Vaccine approaches for antigen capture by liposomes
Shiqi Zhou, Yuan Luo, Jonathan F. Lovell
Expert Review of Vaccines (2023) Vol. 22, Iss. 1, pp. 1022-1040
Open Access | Times Cited: 14
Erythrocyte invasion-neutralising antibodies prevent Plasmodium falciparum RH5 from binding to basigin-containing membrane protein complexes
Abhishek Jamwal, Cristina CONSTANTIN, Stephan Hirschi, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 13
Preclinical Development of a Stabilized RH5 Virus-Like Particle Vaccine that Induces Improved Anti-Malarial Antibodies
Lloyd D. W. King, David Pulido, Jordan R. Barrett, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
A Pfs48/45-based vaccine to block Plasmodium falciparum transmission: phase 1, open-label, clinical trial
Mark J. Alkema, Martine J. Smit, Catherin Marin-Mogollon, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Development of an improved blood-stage malaria vaccine targeting the essential RH5-CyRPA-RIPR invasion complex
Barnabas G. Williams, Lloyd D. W. King, David Pulido, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top